Amwill Health Care Business Update

Amwill Health Care Dividend

Amwill Health Care's board declared an interim dividend of Rs.0.05 per equity share for FY 2026-27 on 23 October 2026. The record date is 30 October 2026 and payment is proposed by 22 November 2026.

Amwill Health Care H1 FY27 Results: Net Profit ₹3.7 Cr, Down 50.7% YoY

Amwill Health Care Ltd reported revenue from operations of ₹22.6 Cr (-7.0% YoY) and net profit of ₹3.7 Cr (-50.7% YoY) for H1 FY27.

Key figure

Net profit ₹3.7 Cr · -50.7% YoY

Amwill Health Care Board Meeting Date

Amwill Health Care has scheduled a board meeting for October 23, 2026, to review H1 financial results and consider declaring an interim dividend.

Amwill Health Care Other Announcement

This filing is a standard quarterly Shareholding Pattern submission in accordance with SEBI Regulation 31(1)(b) for Amwill Health Care Ltd as of September 30, 2026.

Amwill Health Care Regulatory Approval

Amwill Health Care received an import license from CDSCO for FoliColor hair products, enabling the company to commence commercial sale and import into India.

Amwill Health Care Acquisition Worth ₹3 Cr

Amwill Health Care Limited approved investments of ₹3 Crore into two Alternative Investment Funds. The company will invest ₹1.50 Crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.

Value

₹3.00 Cr

Execution

Ensuing month(s)

OnMobile Global Business Update

OnMobile Global Limited executed a distribution agreement with Savex Technologies Private Limited for its ONMO+ Smart Console in India. The counterparty is unrelated and no shares were issued, so no value is disclosed.

OnEMI Technology Solutions Business Update

OnEMI Technology Solutions (Kissht) disclosed its Key Performance Indicators for the quarter ended 30 September 2026. The KPIs, including those defined in its May 2026 prospectus, are published on the company website.

Hero MotoCorp Business Update

Hero MotoCorp updated its code of practices for fair disclosure of unpublished price-sensitive information, effective 28 October 2026. The revised code governs disclosure, spokespersons and analyst interactions.

Cybele Industries Business Update

Cybele Industries disclosed joint venture discussions with a third party, still at an initial stage. No agreement has been executed and no value is stated.

Dr. Reddy's Laboratories Business Update

Dr Reddy's says USFDA closed its PAI and GMP inspection at Srikakulam FTO-SEZ Process Unit-02 with VAI classification. The outcome is closed with no monetary penalty.

Vascon Engineers Business Update

Vascon Engineers awarded Neobridge Realty LLP a Rs.72 Crore shell and core work contract over 25 months. The contract is excluding GST and is described as ordinary course of business.

Value

₹72.00 Cr

Execution

25 months